Surgical management of resectable non-small cell lung cancer: Towards new paradigms

Bulletin du cancer
Mathilde PrietoMarco Alifano

Abstract

Adapting therapies and providing personalized care for patients with resectable non-small cell lung cancer represent major challenges. This involves integrating several parameters into the patient's management, not only crude pathologic results, but also a better understanding of the mechanisms involved in tumor progression. Many studies have looked at the impact of host and tumor characteristics and their interactions through inflammatory processes or tumor immune environment. Beyond tumor stage, poor nutrition, sarcopenia and inflammatory state have been identified as independent factors that can directly impact postoperative outcome. The development of Enhanced Recovery After Surgery (ERAS), in which patient becomes the main player in their own management, seems to be an interesting answer since it seems to allow a reduction in postoperative complications, length of stay and indirectly reduction in costs. A broader and more complete vision including morphometric evaluation of the patient, physical performances, inflammatory state and nutritional state would provide additional discriminating information which can predict postoperative outcome and help in adapting therapies in a personalized way.

References

Jul 5, 2003·The Annals of Thoracic Surgery·Nicolas VenissacJèrôme Mouroux
Sep 28, 2005·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Jérôme MourouxMichel Poudenx
Feb 14, 2006·American Journal of Respiratory and Critical Care Medicine·Olivier SchusslerJean-François Regnard
Nov 17, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Antonio BobbioDario Olivieri
Apr 1, 2008·The Journal of Thoracic and Cardiovascular Surgery·Rocco TrisoliniMarco Patelli
May 21, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Bernd M MuehlingKarl-Heinz Orend
May 24, 2008·The Annals of Thoracic Surgery·Marco AlifanoJean-François Régnard
Nov 22, 2008·The Annals of Thoracic Surgery·Olivier SchusslerJean François Regnard
Jan 14, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Antonio BobbioDario Olivieri
Sep 3, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco AlifanoPatricia Forgez
Aug 30, 2011·The Journal of Thoracic and Cardiovascular Surgery·Marco AlifanoJean-François Régnard
Feb 19, 2013·The Annals of Thoracic Surgery·Salvatore StranoMarco Alifano
Jun 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Romain RemarkDiane Damotte
Sep 26, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Pascal Alexandre ThomasUNKNOWN EPITHOR Group
Feb 4, 2014·American Journal of Respiratory and Critical Care Medicine·Claire GermainMarie-Caroline Dieu-Nosjean
Jul 5, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Antonio Bobbio, Marco Alifano
May 7, 2016·Integrative Cancer Therapies·Maja S SommerHenning Langberg
Jun 15, 2016·American Journal of Respiratory and Critical Care Medicine·Audrey Mansuet-LupoDiane Damotte
Sep 24, 2016·The Annals of Thoracic Surgery·Remi HervochonMarco Alifano
Mar 9, 2018·American Journal of Respiratory and Critical Care Medicine·Jérôme BitonDiane Damotte
Apr 20, 2018·Interactive Cardiovascular and Thoracic Surgery·Ludovic FournelMarco Alifano
Jun 3, 2018·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Philippe IcardHubert Lincet
Aug 1, 2018·The Journal of Thoracic and Cardiovascular Surgery·Kim BlancAntoine Rabbat
Oct 30, 2018·Journal of Thoracic Disease·Philippe IcardMarco Alifano
Nov 27, 2018·The Annals of Thoracic Surgery·Mauro LoiMarco Alifano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Lizza E HendriksAnne-Marie Dingemans
Journal of Thoracic Disease
Felipe Cardenal, Ramón Palmero
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Jordyn Vernon, Waël C Hanna
© 2021 Meta ULC. All rights reserved